Quick Dispatch:
Your glp-1 for iih Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 for iih Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study ships.
Need Help?
Questions about glp-1 for iih Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 for iih Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study in your area.
Novel use of GLP-1 receptor agonist therapy for pediatric idiopathic intracranial hypertension: a case report
29.79
IIH (Idiopathic Intracranial Hypertension): Symptoms, Diagnosis & Treatment
20.16
A retrospective cohort study assessed outcomes among patients with idiopathic intracranial hypertension who received glucagon-like peptide-1 receptor agonists
21.79
Association between GLP-1 receptor agonist use and neurosurgical intervention in patients with idiopathic intracranial hypertension and obesity: a propensity-matched, multi-institutional, cohort study
29.49
GLP-1 medications and pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih
26.71
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain
20.47
The protective role of GLP-1 in neuro-ophthalmology
23.67
